Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

EssilorLuxottica Shares Drop 4.42% Midday Amid Google Pressure

EssilorLuxottica shares experienced a significant decline on Tuesday, December 9, falling 4.42% to 289.80 euros by midday. This downturn follows Alphabet's announcement of developing new smart glasses, challenging the Franco-Italian group's near-monopoly in this strategic segment.


EssilorLuxottica Shares Drop 4.42% Midday Amid Google Pressure

EssilorLuxottica Shares Fall 4.42% to 289.80 Euros at Midday on December 9

EssilorLuxottica shares have fallen 4.42% to 289.80 euros at midday on December 9, with trading volumes representing 0.04% of the capital. This decline, following a previous close at 303.20 euros, marks a sharp halt in the stock's trajectory. The Franco-Italian group, a leader through its Ray-Ban brand via a partnership with Meta, faces imminent competition from Google, which is reportedly developing two models of glasses in collaboration with Samsung, Warby Parker, and Gentle Monster. This news heavily impacts a stock that has seen a weekly decline of 5.6% but still boasts flattering performances over three months (+10.61%) and one year (+25.67%), significantly outperforming the CAC 40 (+8.65% over one year). It is worth noting recent executive movements with two purchases totaling 1,500 shares for approximately 477,050 euros and a sale of 500 shares.

Technical Analysis Indicates Weakening Short-Term Momentum

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Technically, the stock is now trading below its 50-day moving average, which stands at 303.01 euros, signaling a weakening of short-term momentum. The RSI at 39 points suggests a relative oversold zone without reaching extreme levels, hinting at a possible stabilization in upcoming sessions. A negative MACD histogram at -0.67 confirms this loss of bullish momentum that started several sessions ago. The stock is currently testing a major support level at 302.60 euros, which, if broken, could lead to a move towards the lower Bollinger bands at 299.38 euros. Volatility remains moderate at 4.83 over a month, reflecting a market that is digesting the information without excessive panic.

Sectoral Context Grows Complex with New Tech Announcement

The sectoral context is becoming more complex with this technological announcement that challenges EssilorLuxottica's privileged positioning in the smart glasses market. The group, which capitalizes on its exclusive partnership with Meta and the success of connected Ray-Bans, now faces a significant competitor with the Alphabet ecosystem. The Paris market also shows a negative tone with the CAC 40 down 0.48% at 8,069.61 points. Investors are adopting a wait-and-see approach, closely monitoring the Franco-Italian leader's ability to maintain its technological lead in the face of this announced competition. The 200-day moving average, positioned at 267.11 euros, remains well below the current prices, indicating an underlying trend that remains constructive despite this technical correction.



Sector Luxe Fournitures Médicales


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 28 491 millions d'euros
  • Revenue growth: 11,2 %
  • EBITDA: 6 492 millions d'euros
  • EBITDA margin: 22,8 %
  • Net income: 2 443 millions d'euros
  • Free cash flow: 2 796 millions d'euros
  • Net debt: 10 853 millions d'euros
  • Dividend per share: 4,00 euros
Guidance from the release
  • C’est une année historique pour EssilorLuxottica : pour la première fois depuis l’origine du Groupe, notre chiffre d’affaires a enregistré une croissance à deux chiffres à taux de change constant, après un quatrième trimestre affichant une croissance record de 18,4 %.
  • Résultats annuels 2025 marquent une croissance du chiffre d’affaires de 11,2% et une marge opérationnelle ajustée de 15,7%; le cash-flow libre atteint 2,8 milliards d'euros; dividende proposé de 4,00 euros; acquisitions et initiatives med-tech renforcent le positionnement.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit